ELIMINATION OF ANTIPYRINE AND ITS METABOLITES IN INTERFERON-TREATED HEPATITIS-C

被引：4

作者：

SIECK, JO

ELYAZIGI, A

ALI, H

DOSSING, M

SAOUR, J

RAINES, DA

ERNST, P

机构：

[1] BISPEBJERG HOSP,DEPT MED P,DK-2400 COPENHAGEN,DENMARK

[2] KING FAISAL SPECIALIST HOSP & RES CTR,DEPT MED,RIYADH 11211,SAUDI ARABIA

[3] KING FAISAL SPECIALIST HOSP & RES CTR,DEPT BIOL & MED RES,RIYADH 11211,SAUDI ARABIA

[4] KING FAISAL SPECIALIST HOSP & RES CTR,DEPT ONCOL,RIYADH 11211,SAUDI ARABIA

来源：

HUMAN & EXPERIMENTAL TOXICOLOGY | 1994年 / 13卷 / 09期

关键词：

D O I：

10.1177/096032719401300902

中图分类号：

R99 [毒物学（毒理学）];

学科分类号：

100405 ;

摘要：

1 To study the effect of interferon on hepatic drug metabolism in chronic hepatitis C, we examined nine patients before and at the end of 6 months of interferon treatment. 2 Routine liver function was determined together with the salivary clearance of antipyrine and the 48 h urinary excretion of the main metabolites of antipyrine: 4-hydroxyantipyrine 3-hydroxymethylantipyrine and norantipyrine before and after 6 months of interferon treatment. 3 Liver pathology, routine liver function, and antipyrine metabolism remained unchanged after patients were treated for 6 months with interferon for a histologically advanced but clinically compensated chronic hepatitis C. ,

引用

页码：598 / 601

页数：4

共 50 条

[31] ANTIPYRINE CLEARANCE AND METABOLITE EXCRETION IN PATIENTS WITH CHRONIC HEPATITIS-C
ALI, HA
ELYAZIGI, A
SIECK, JO
ALI, MA
RAINES, DA
SAOUR, J
ERNST, P
KHAN, B
DOSSING, M
JOURNAL OF HEPATOLOGY, 1995, 22 (01) : 17 - 21
[32] CONCURRENT HEPATITIS-B AND HEPATITIS-C INFECTION TREATED SUCCESSFULLY WITH ALPHA-INTERFERON
BURT, MJ
CHAPMAN, BA
SCRIMSHAW, BJ
JENNINGS, LC
GEORGE, PM
AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1993, 23 (04): : 411 - 412
[33] SELECTION OF MORE PATHOGENIC HEPATITIS-C VIRUS GENOTYPE-II DURING LONG-TERM FOLLOW-UP OF INTERFERON-TREATED PATIENTS
VILLA, E
BUTTAFOCO, P
MERIGHI, A
GROTTOLA, A
FERRETTI, I
FERRARI, A
CALLEA, F
TRANDE, P
REBECCHI, AM
MANENTI, F
JOURNAL OF MOLECULAR MEDICINE-JMM, 1995, 73 (05): : 249 - 254
[34] HCV RNA IN PATIENTS WITH CHRONIC HEPATITIS-C TREATED WITH INTERFERON-ALPHA
LIANG, TJ
RUSTGI, V
GALUN, E
BLUM, HE
JOURNAL OF MEDICAL VIROLOGY, 1993, 40 (01) : 69 - 75
[35] ENDOCRINE EVALUATION IN PATIENTS TREATED WITH INTERFERON-ALPHA FOR CHRONIC HEPATITIS-C
DELMONTE, P
BERNASCONI, D
DECONCA, V
RANDAZZO, M
MEOZZI, M
BADARACCO, B
MESITI, S
MARUGO, M
HORMONE RESEARCH, 1995, 44 (03) : 105 - 109
[36] SERIAL DENSITY ANALYSIS OF HEPATITIS-C VIRUS PARTICLE-POPULATIONS IN CHRONIC HEPATITIS-C PATIENTS TREATED WITH INTERFERON-ALPHA
KANTO, T
HAYASHI, N
TAKEHARA, T
HAGIWARA, H
MITA, E
OSHITA, M
KATAYAMA, K
KASAHARA, A
FUSAMOTO, H
KAMADA, T
JOURNAL OF MEDICAL VIROLOGY, 1995, 46 (03) : 230 - 237
[37] QUANTITATION OF HEPATITIS-C VIRUS-RNA IN PATIENTS WITH ACUTE HEPATITIS-C TREATED WITH HIGH-DOSE ALPHA-INTERFERON
VOGEL, W
UMLAUFT, F
GRAZAIDEI, I
DATZ, C
GRUNEWALD, K
HEPATOLOGY, 1994, 20 (04) : A411 - A411
[38] 3 CASES OF POSTTRANSFUSION HEPATITIS-C TREATED WITH INTERFERON-ALPHA - CONFIRMATION OF A CARRIER STATE BY DETECTION OF HEPATITIS-C VIRUS-RNA AFTER INTERFERON THERAPY
HAGIWARA, H
HAYASHI, N
KASAHARA, A
MITA, E
TAKEHARA, T
FUSAMOTO, H
KAMADA, T
DIGESTIVE DISEASES AND SCIENCES, 1992, 37 (04) : 631 - 634
[39] Immune-mediated complications of the graft in interferon-treated hepatitis C positive liver transplant recipients
Selzner, Nazia
Guindi, Maha
Renner, Eberhard L.
Berenguer, Marina
JOURNAL OF HEPATOLOGY, 2011, 55 (01) : 207 - 217
[40] The viral clearance in interferon-treated chronic hepatitis C is associated with increased cytotoxic T cell frequencies
Löhr, HF
Schmitz, D
Arenz, M
Wever, S
Gerken, G
zum Büschenfelde, KHM
HEPATOLOGY, 1998, 28 (04) : 167A - 167A

← 1 2 3 4 5 →